A case report details a decade-long treatment journey for a patient with steroid-dependent IgA nephropathy and minimal change disease, transitioning from immunosuppressants to rituximab and obinutuzumab. This highlights evolving therapeutic strategies for managing this rare condition.
decade long journey of steroid dependent iga nephropathy with minimal change disease from immunosuppressants to rituximab and then to obinutuzumab a case report
Original title: “A Decade-Long Journey of Steroid-Dependent IgA Nephropathy with Minimal Change Disease from Immunosuppressants to Rituximab and then to Obinutuzumab: A Case Report.”